Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2022SHILAP Revista de lepidopterologíaOpen Access

Bone marrow mesenchymal stromal cells for diabetes therapy: touch, fuse, and fix?

View Full Paper
Ask AI
Bookmark
Share

Authors

ZAZahra AziziRARoya AbbaszadehRSRoxana Sahebnasagh

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Azizi et al. (2022) studied this question.

synapsesocial.com/papers/69dcc42df729781886359801https://doi.org/10.1186/s13287-022-03028-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers2020 · 88 citations
  2. 2Systemic therapy of MSCs in bone regeneration: a systematic review and meta-analysis2021 · 84 citations
  3. 3Stromal Cell–Derived Factor-1 (SDF-1)/CXCL12 Attenuates Diabetes in Mice and Promotes Pancreatic β-Cell Survival by Activation of the Prosurvival Kinase Akt2007 · 129 citations
  4. 4Systematic Review of Stem-Cell-Based Therapy of Burn Wounds: Lessons Learned from Animal and Clinical Studies2020 · 18 citations
  5. 5Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus2019 · 40 citations